Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Include planned cycle length and rest periods
Mole changes, however, may persist and require ongoing monitoring
Active Ingredient Semaglutide (Advanced GLP-1 Receptor Agonist) Total Strength per Vial 2 mg Semaglutide solution Dose Classification Advanced Titration & Plateau-Breaking Tier Primary Manufacturer Glenmark Pharmaceuticals Ltd Therapeutic Class Incretin Mimetic / Antidiabetic / Anti-Obesity Administration Route Subcutaneous Injection (Weekly advanced baseline) Supply Format 1 Multi-dose Vial / Pen System
Peptide Blends Fragment 176-191 & Mod GRF 1-29 & Ipamorelin Blend (12mg) $87.00 BPC-157 & TB-500 Blend (10mg) $115.00 CJC-1295 & GHRP-6 Blend (10mg) $86.00 CJC-1295 & Ipamorelin Blend (10mg) $81.00 CJC-1295 (Mod GRF 1-29) & Ipamorelin & GHRP-2 Blend (9mg) $80.00 Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) $87.00 Mod GRF 1-29 & GHRP-2 Blend (10mg) $84.00 Mod GRF 1-29 & Ipamorelin Blend (10mg) $81.00
Data for analysis was excluded if access resistance is more than 50 Mohm or membrane resistance is less than 100 Mohm
A significant decrease in arachidonate levels (20:4n-6) may be the cause of anti-inflammatory effects
US$ 24.13
US$ 22.89
US$ 20.30
